Research and Markets: This Essential Report Comprehensively Examines the Indian Pharmaceutical Industry
Posted on: Friday, 31 October 2008, 09:00 CDT
Research and Markets (http://www.researchandmarkets.com/research/45cca1/indian_pharmaceuti) has announced the addition of the "Indian Pharmaceutical Industry" report to their offering.
The Indian pharmaceutical industry grew at 13% during 2003-2007, driven by rising consumption levels in the country and strong demands from export markets. In 2006-07, the Indian pharma market reached US 8.16 billion and is estimated to reach US 9.77 billion in 2007-08. At present, India's pharmaceutical industry constitutes 1-2% of the global pharmaceutical market in value terms.
Key Findings & Highlights:
- The market is estimated to register sales of US 743 billion in 2008 with a growth of 5-6% compared with 6-7% in 2007.
- In 2007, 71% of oncology product sales came from the US and Europe's top five markets - France, Germany, Italy, the UK and Spain.
- The growth accelerates in the seven "pharmerging" markets of China, Brazil, Mexico, South Korea, India, Turkey and Russia and is expected to grow by 12-13% in 2008 to US 85-90 billion.
- Generic producing companies Barr, Ranbaxy, Mylan, Teva, Actavis and Dr Reddy's Labs have become dominant as they keep launching more and more generics.
- In world rankings, the Indian pharmaceutical industry stood fourth in terms of volume and 13th in terms of value in 2006-07.
- Exports are bifurcated into exports services comprising contract manufacturing, contract research.
- India currently has more than 80 FDA-approved plants, followed by Italy (55) and China (27).
Your Questions Answered:
- What is the expected growth in the seven "pharmerging" markets across the world
- What is the % of product sales came from US & Europe's Top five markets
- What are the primary growth drivers in pharma industry
- Why companies are increasingly turning to licensing
- What are the drugs dominated domestic retail pharma market in 2007
Key Topics Covered:
1. INDUSTRY OVERVIEW - Global and Domestic
2. Foreign Trade in Pharmaceutical Industry
3. GROWTH DRIVERS
4. ISSUES & CHALLENGES
5. MAJOR PLAYERS
6. OUTSOURCING OPPORTUNITIES
7. Generic Opportunities
8. REGULATORY ISSUES
9. CRITICAL SUCCESS FACTORS
10. Future Outlook
Companies Mentioned:
- Ranbaxy Laboratories Ltd
- Dr Reddy's Laboratories Ltd
- Cipla Ltd
- Sun Pharmaceutical Industries Ltd
- Piramal Healthcare Ltd
- Lupin Ltd
- Wockhardt Ltd
- Jubilant Organosys
- Aurobindo Pharma Ltd
- Cadila Healthcare Ltd
- Glenmark Pharmaceuticals Ltd
- Matrix Laboratories
- GlaxoSmithKline Pharmaceuticals Ltd
- Torrent Pharmaceuticals
- Orchid Chemicals and Pharmaceuticals Ltd
- Ipca Laboratories Ltd
- Biocon Limited
- Divis laboratories
- Alembic Ltd
- Aventis Pharma Ltd
For more information visit http://www.researchandmarkets.com/research/45cca1/indian_pharmaceuti
Source: Business Wire
Related Articles
- Kenyan Pharmaceutical Industry Can Expect Significant Growth Despite Global Conditions, Finds Frost & Sullivan
- IPS and Wuhan Pharmaceutical Industry Design Institute Partnership Announce Agreement
- Pharmaceutical Margins Will Come Under Extreme Pressures in 2008 and Beyond According to Recent Report State of the Pharmaceutical Industry, 2008
- Discover the Issues That Will Both Concern and Excite the Pharmaceutical Industry in 2008 in This Specialised Report
- New Report 'Analyzing the Global Pharmaceutical Industry' Takes a Critical View on the Irresponsible Drug Promotion and Advertising Practiced By Some Pharma Companies
- There Was an Average Annual Growth of 19.2% From 2000 to 2005 in the Chinese Pharmaceutical Industry
- Research and Markets: The Evolving Strategies of Generics Company Teva and the Growing Acceptance of Generic Drugs in Japan, Read More Inside 'State of the Pharmaceutical Industry, 2007'
- Teva Pharmaceutical Industries, Ltd. (TEVA) President, CEO, CFO and Chairman of the Board to Ring the NASDAQ Stock Market Opening Bell
- In Brazil Seven Out of Ten Purchases at Drugstores Are Not Sold Under a Doctors' Prescription Therefore the Success of a New Drug or New Concept is Only Partially in the Hands of Doctors - The Image of Pharmaceutical Industry in Brazil
 |
 |
User Comments (0)
RSS Feeds